Videos

The information on this page is not a substitute for the information in our product labeling and is a supplement to the training you receive from your Eversense Clinical Training Manager.

Eversense Procedure Video

Eversense E3 Sensor Insertion & Removal Video

Create a Sterile Field

Creating a Sterile Field for the Eversense CGM System – English

Creating a Sterile Field for the Eversense CGM System – German

Creating a Sterile Field for the Eversense CGM System – Italian

Creating a Sterile Field for the Eversense CGM System – French

Creating a Sterile Field for the Eversense CGM System – Swedish

MKT-001616 Rev 1

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more. For important safety information, see https://global.eversensediabetes.com/safety-information/.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.  For important safety information, see https://global.eversensediabetes.com/safety-information/